Anti-Jo-1 positive inclusion body myositis with a marked and sustained clinical improvement after oral prednisone [5]

Journal of Neurology Neurosurgery and Psychiatry

Volumn 70, Issue 5, 2001, Pages 706-

  Hengstman, G J D ^a   Ter Laak, H J ^a   Van Engelen, B G M ^a   Van Venrooij, W J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; PREDNISONE;

AGED; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; DERMATOMYOSITIS; DIFFERENTIAL DIAGNOSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCLUSION BODY MYOSITIS; LETTER; MALE; POLYMYOSITIS; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; AGED; HISTIDINE-TRNA LIGASE; HUMANS; MALE; MYOSITIS, INCLUSION BODY; PREDNISONE;

EID: 0035043073     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.70.5.706     Document Type: Letter

References (5)

1. Polymyositis, dermatomyositis and inclusion-body myositis
2. Inclusion body myositis and myopathies
3. Anti-Ro52 antibodies frequently co-occur with anti-Jo-1 antibodies in sera from patients with idiopathic inflammatory myopathy
4. Presence of the anti-Jo-1 autoantibody excludes inclusion body myositis
5. Immune-mediated conditions and antibodies associated with sporadic inclusion body myositis